Cited by 882Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex

Open access

Mirnics, Károly, Middleton, Frank A., Marquez, Adriana, Lewis, David A., Levitt, Pat·2000·Neuron

DOI 10.1016/s0896-6273(00)00085-4

Open this paper in CoChat — free account Open PDF

Abstract

Microarray expression profiling of prefrontal cortex from matched pairs of schizophrenic and control subjects and hierarchical data analysis revealed that transcripts encoding proteins involved in the regulation of presynaptic function (PSYN) were decreased in all subjects with schizophrenia. Genes of the PSYN group showed a different combination of decreased expression across subjects. Over 250 other gene groups did not show altered expression. Selected PSYN microarray observations were verified by in situ hybridization. Two of the most consistently changed transcripts in the PSYN functional gene group, N-ethylmaleimide sensitive factor and synapsin II, were decreased in ten of ten and nine of ten subjects with schizophrenia, respectively. The combined data suggest that subjects with schizophrenia share a common abnormality in presynaptic function. We set forth a predictive, testable model.

Integrity signals

Registry

Crossref · 10.1016/s0896-6273(00)00085-4

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citation
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Exploring the new world of the genome with DNA microarrays
Brown, P. O., & Botstein, D. (1999) · Nature Genetics · doi:10.1038/4462 · Cited by 2,430
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
The synaptic vesicle cycle: a cascade of protein–protein interactions
Südhof, T. C. (1995) · Nature · doi:10.1038/375645a0 · Cited by 1,991
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Expression profiling using cDNA microarrays
Duggan, D. J., Bittner, M. L., Chen, Y., Meltzer, P. S., & Trent, J. M. (1999) · Nature Genetics · doi:10.1038/4434 · Cited by 1,660
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Self-citation

Show all 105 references

Research works printed but not linked: 3

Lewis, 2000, Catching up with schizophrenia, Neuron, in press
Volk, 2000, Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in schizophrenia, Arch. Gen. Psychiatry, in press
Weinberger, 1999, Schizophrenia, Biol. Psychiatry, 46, 3

Sorted by citations

Items 201–300 of 880

Synapsin Isoforms and Synaptic Vesicle Trafficking
Song, S., & Augustine, G. J. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0233 · Cited by 109
Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients
Prasad, K. M. R., Chowdari, K. V., Nimgaonkar, V. L., Talkowski, M. E., Lewis, D. A., & Keshavan, M. S. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001562 · Cited by 106
Self-citation
Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
Weickert, C. S., Sheedy, D. L., Rothmond, D. A., Dedova, I. V., Fung, S. J., Garrick, T. M., Wong, J., Harding, A. J., Sivagnanansundaram, S., Hunt, C. E., et al. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903393662 · Cited by 110
Deciphering the Disease Process of Schizophrenia: The Contribution of Cortical Gaba Neurons
Lewis, D. A., & Hashimoto, T. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78004-7 · Cited by 106
Self-citation
Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence
Sokolov, B. P., Jiang, L., Trivedi, N. S., & Aston, C. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10631 · Cited by 105
DNA microarray analysis of the contused spinal cord: Effect of NMDA receptor inhibition
Nesic, O., Svrakic, N. M., Xu, G., McAdoo, D. J., Westlund, K. N., Hulsebosch, C. E., Ye, Z., Galante, A., Soteropoulos, P., Tolias, P. P., et al. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10171 · Cited by 102
Schizophrenia susceptibility genes: emergence of positional candidates and future directions
Gogos, J. A., & Gerber, D. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.005 · Cited by 103
Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types
Dorph‐Petersen, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20055 · Cited by 102
Self-citation
Developmentally Regulated Switch in Alternatively Spliced SNAP-25 Isoforms Alters Facilitation of Synaptic Transmission
Bark, C., Bellinger, F. P., Kaushal, A., Mathews, J. R., Partridge, L. D., & Wilson, M. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1940-04.2004 · Cited by 101
Transcriptome Sequencing Revealed Significant Alteration of Cortical Promoter Usage and Splicing in Schizophrenia
Wu, J. Q., Wang, X., Beveridge, N. J., Tooney, P. A., Scott, R. J., Carr, V. J., & Cairns, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036351 · Cited by 103
Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia
Inan, M., Petros, T. J., & Anderson, S. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.013 · Cited by 105
Making the Case for a Candidate Vulnerability Gene in Schizophrenia: Convergent Evidence for Regulator of G-Protein Signaling 4 (RGS4)
Levitt, P. R., Ebert, P. J., Mirnics, K., Nimgaonkar, V. L., & Lewis, D. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.028 · Cited by 100
Self-citation
Neuroproteomics: Expression Profiling of the Brain's Proteomes in Health and Disease
Kim, S. I., Voshol, H., van Oostrum, J., Hastings, T. G., Cascio, M., & Glucksman, M. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023618.35579.7c · Cited by 104
Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood
Glorioso, C. A., Sabatini, M., Unger, T. L., Hashimoto, T., Monteggia, L. M., Lewis, D. A., & Mirnics, K. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001835 · Cited by 102
Self-citation
The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics
Costa, E. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00121-7 · Cited by 102
Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness
Sawada, K., Young, C. E., Barr, A. M., Longworth, K., Takahashi, S., Arango, V., Mann, J. J., Dwork, A. J., Falkai, P., Phillips, A. G., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000978 · Cited by 99
Expressing what's on your mind: DNA arrays and the brain
Lockhart, D. J., & Barlow, C. (2001) · Nature reviews. Neuroscience · doi:10.1038/35049070 · Cited by 99
Single-Cell Gene Expression Analysis: Implications for Neurodegenerative and Neuropsychiatric Disorders
Ginsberg, S. D., Elarova, I., Ruben, M., Tan, F., Counts, S. E., Eberwine, J. H., Trojanowski, J. Q., Hemby, S. E., Mufson, E. J., & Che, S. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023593.77052.f7 · Cited by 97
Translational research in central nervous system drug discovery
Hurko, O., & Ryan, J. L. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.671 · Cited by 96
Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach
Rodd, Z. A., Bertsch, B. A., Strother, W. N., Le-Niculescu, H., Balaraman, Y., Hayden, E. P., Jerome, R. E., Lumeng, L., Nürnberger, J. I., Edenberg, H. J., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500420 · Cited by 95
Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96
Gamma oscillation deficits and the onset and early progression of schizophrenia
Woo, T.-U. W., Spencer, K., & McCarley, R. W. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747609 · Cited by 96
Chronic Olanzapine Treatment Causes Differential Expression of Genes in Frontal Cortex of Rats as Revealed by DNA Microarray Technique
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., Bell, C., Nos, L., Fried, P., Pearce, D. A., Singh, S., Siderovski, D. P., Willard, F. S., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301002 · Cited by 97
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95
Comparative genome‐ and proteome analysis of cerebral cortex from MK‐801‐treated rats
Paulson, L., Martin, P., Persson, A. I., Nilsson, C. L., Ljung, E., Brinkmalm, A., Eriksson, P. S., Blennow, K., & Davidsson, P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10509 · Cited by 95
The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: insights from computational modeling
Spencer, K. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.033.2009 · Cited by 102
Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients
Bubber, P., Hartounian, V., Gibson, G. E., & Blass, J. P. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.10.007 · Cited by 95
H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression
Cruceanu, C., Alda, M., Nagy, C., Freemantle, E., Rouleau, G. A., & Turecki, G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000363 · Cited by 93
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications
Gaspar, P. A., Bustamante, M. L., Hernán Silva, I., & Aboitiz, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06325.x · Cited by 91
Increased levels of SNAP‐25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder
Scarr, E., Gray, L., Keriakous, D., Robinson, P. J., & Dean, B. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00300.x · Cited by 98
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers
Mexal, S., Frank, M., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., & Leonard, S. S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.06.006 · Cited by 93
Genome-wide expression profiling of schizophrenia using a large combined cohort
Mistry, M., Gillis, J. A., & Pavlidis, P. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.172 · Cited by 92
Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia
Devor, A., Andreassen, O. A., Wang, Y., Mäki‐Marttunen, T., Smeland, O. B., Fan, C.-C., Schork, A. J., Holland, D., Thompson, W. K., Witoelar, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.33 · Cited by 91
Schizophrenia as a Disorder of Molecular Pathways
Horváth, S., & Mirnics, K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.001 · Cited by 90
Self-citation
MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice
Mitchell, A., Javidfar, B., Pothula, V., Ibi, D., Shen, E., Peter, C. J., Bicks, L. K., Fehr, T., Jiang, Y., Brennand, K., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.254 · Cited by 88
Involvement of gene–diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia
Singh, S., Murphy, B., & O’Reilly, R. (2003) · Clinical Genetics · doi:10.1046/j.1399-0004.2003.00190.x · Cited by 92
Design and analysis issues in genome-wide somatic mutation studies of cancer
Parmigiani, G., Boca, S. M., Lin, J., Kinzler, K. W., Velculescu, V. E., & Vogelstein, B. (2008) · Genomics · doi:10.1016/j.ygeno.2008.07.005 · Cited by 89
MOLECULAR NETWORKS IN MICROARRAY ANALYSIS
Sivachenko, A., Yuryev, A., Daraselia, N., & Mazo, I. A. (2007) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720007002795 · Cited by 89
Gene Expression Profile in Interleukin-4-Stimulated Human Vascular Endothelial Cells
Lee, Y. W., Eum, S. Y., Chen, K. C., Hennig, B., & Toborek, M. (2004) · Molecular Medicine · doi:10.2119/2004-00024.lee · Cited by 88
Epigenetic mechanisms in schizophrenia
Akbarian, S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/sakbarian · Cited by 89
Gene Expression of Metabolic Enzymes and a Protease Inhibitor in the Prefrontal Cortex Are Decreased in Schizophrenia
Vawter, M. P., Weickert, C. S., Ferran, E., Matsumoto, M., Overman, K., Hyde, T. M., Weinberger, D. R., Bunney, W. E., & Kleinman, J. E. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023611.99452.47 · Cited by 89
Imaging Normal and Abnormal Brain Development: New Perspectives for Child Psychiatry
Rapoport, J. L., Castellanos, F. X., Gogate, N., Janson, K., Kohler, S. J., & Nelson, P. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00900.x · Cited by 88
Microarray Applications in Neuroscience
Luo, Z., & Geschwind, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0387 · Cited by 88
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse
Lehrmann, E., Oyler, J. M., Vawter, M. P., Hyde, T. M., Kolachana, B. S., Kleinman, J. E., Huestis, M. A., Becker, K. G., & Freed, W. J. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500146 · Cited by 87
Functional genomics and proteomics: application in neurosciences
Wilson, K. E. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.026260 · Cited by 87
Evidence for Abnormal Forward Trafficking of AMPA Receptors in Frontal Cortex of Elderly Patients with Schizophrenia
Hammond, J. C., McCullumsmith, R. E., Funk, A. J., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.87 · Cited by 86
Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients
Dutta, R., McDonough, J. A., Chang, A., Swamy, L., Siu, A., Kidd, G. J., Rudick, R. A., Mirnics, K., & Trapp, B. D. (2007) · Brain · doi:10.1093/brain/awm206 · Cited by 87
Self-citation
Gene Expression Profiling in Schizophrenia and Related Mental Disorders
Iwamoto, K., & Kato, T. (2006) · The Neuroscientist · doi:10.1177/1073858406287536 · Cited by 88
Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders
Xing, G., Zhang, L., Russell, S., & Post, R. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.11.006 · Cited by 85
The Human Genome Project and Its Impact on Psychiatry
Cowan, W. M., Kopnisky, K. L., & Hyman, S. E. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142853 · Cited by 86
Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments
Rubio, M. D., Drummond, J. B., & Meador‐Woodruff, J. H. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.1.001 · Cited by 88
Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines.
Rogojina, A. T., Orr, W. E., Song, B. K., & Geisert, E. E. (2003) · PubMed · Cited by 83
Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis
Novikova, S. I., He, F., Cutrufello, N. J., & Lidow, M. S. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.002 · Cited by 83
Oligodendrocyte pathophysiology: a new view of schizophrenia
Segal, D., Koschnick, J. R., Slegers, L. H. A., & Hof, P. R. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570600722x · Cited by 82
Persistent, non‐cytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF‐induced synaptogenesis
Hans, A., Bajramovic, J. J., Syan, S., Perret, E., Dunia, I., Brahic, M., & Gonzalez‐Dunia, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0764fje · Cited by 81
Synaptic Dysfunction in Schizophrenia
Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 85
Recent Advances in the Genetics of Schizophrenia
Avramopoulos, D. (2018) · Complex Psychiatry · doi:10.1159/000488679 · Cited by 84
Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
Junqueira, D. G., Falvella, A. C. B., Antunes, A. S. L. M., Seabra, G., Brandão‐Teles, C., Martins‐de‐Souza, D., & Crunfli, F. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00379 · Cited by 80
Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters
Bogen, I. L., Boulland, J., Mariussen, E., Wright, M., Fonnum, F., Kao, H., & Walaas, S. I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03636.x · Cited by 83
The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia
Rotaru, D. C., Lewis, D. A., & González‐Burgos, G. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2011-0059 · Cited by 81
Self-citation
Gene Expression Profiling in Brodmann's Area 46 from Subjects with Schizophrenia
Dean, B., Keriakous, D., Scarr, E., & Thomas, E. A. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701213245 · Cited by 83
Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia
Lewis, D. A., Hashimoto, T., & Morris, H. M. (2008) · Neurotoxicity Research · doi:10.1007/bf03033813 · Cited by 80
Self-citation
Proteomics in Neuroscience: From Protein to Network
Grant, S. G. N., & Blackstock, W. P. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08315.2001 · Cited by 80
Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons
Habela, C. W., Song, H., & Ming, G. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.12.002 · Cited by 80
Patient-oriented gene set analysis for cancer mutation data
Boca, S. M., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., & Parmigiani, G. (2010) · Genome biology · doi:10.1186/gb-2010-11-11-r112 · Cited by 77
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia
Tucholski, J., Simmons, M. S., Pinner, A. L., Haroutunian, V. H., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.031 · Cited by 77
Antipsychotic drug treatment induces differential gene expression in the rat cortex
Kontkanen, O., Törönen, P., Lakso, M., Wong, G., & Ċastrén, E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01213.x · Cited by 77
Altered Expression of 14-3-3 Genes in the Prefrontal Cortex of Subjects with Schizophrenia
Middleton, F. A., Peng, L., Lewis, D. A., Levitt, P. R., & Mirnics, K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300674 · Cited by 78
Self-citation
Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.029 · Cited by 76
Interfering with the brain: Use of RNA interference for understanding the pathophysiology of psychiatric and neurological disorders
Thakker, D. R., Hoyer, D., & Cryan, J. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.006 · Cited by 78
Over‐Expression of Dopamine D2 Receptor and Inwardly Rectifying Potassium Channel Genes in Drug‐Naive Schizophrenic Peripheral Blood Lymphocytes as Potential Diagnostic Markers
Zvara, Á., Szekeres, G., Janka, Z., Kelemen, J. Z., Cimmer, C., Sántha, M., & Puskás, L. G. (2005) · Disease Markers · doi:10.1155/2005/275318 · Cited by 76
Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
Stoeber, G., Ben‐Shachar, D., Cardon, M., Falkai, P., Fonteh, A. N., Gawlik, M., Glenthoj, B. Y., Grünblatt, E., Jablensky, A. V., Kim, Y., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902898980 · Cited by 76
Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study
Keshavan, M. S., Stanley, J. A., Montrose, D. M., Minshew, N. J., & Pettegrew, J. W. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001325 · Cited by 76
The chandelier neuron in schizophrenia
Lewis, D. A. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20825 · Cited by 76
Self-citation
cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease
Marcotte, E. R., Srivastava, L. K., & Quirion, R. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00086-x · Cited by 75
Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models
Reddy, P. H., & McWeeney, S. K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.014 · Cited by 73
Altered gene expression in the superior temporal gyrus in schizophrenia
Bowden, N. A., Scott, R. J., & Tooney, P. A. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-199 · Cited by 74
Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures
Takahashi, M., Hayashi, H., Watanabe, Y., Sawamura, K., Fukui, N., Watanabe, J., Kitajima, T., Yamanouchi, Y., Iwata, N., Mizukami, K., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.024 · Cited by 75
Schizophrenia, vitamin D, and brain development
Mackay‐Sim, A., Feron, F. P., Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59014-1 · Cited by 76
β-Amyloid Production, Aggregation, and Clearance as Targets for Therapy in Alzheimer's Disease
Felice, F. G. D., & Ferreira, S. T. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1021832302524 · Cited by 75
Schizophrenia as a Disorder of Neuroplasticity
McCullumsmith, R. E., Clinton, S. M., & Meador‐Woodruff, J. H. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59002-5 · Cited by 73
Chapter 4. Personality Disorders and Relational Disorders: A Research Agenda for Addressing Crucial Gaps in DSM
First, M. B., Bell, C. C., Cuthbert, B. C., Krystal, J. H., Malison, R. T., Offord, D. R., Reiss, D., Shea, M. T., Widiger, T., & Wisner, K. L. (2002) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427644.lg04 · Cited by 73
Microarrays in brain research: the good, the bad and the ugly
Mirnics, K. (2001) · Nature reviews. Neuroscience · doi:10.1038/35077587 · Cited by 71
Self-citation
Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
Cuttler, K., Hassan, M., Carr, J. A., Cloete, R. E. A., & Bardien, S. (2021) · Open Biology · doi:10.1098/rsob.210091 · Cited by 69
Brain pH has a significant impact on human postmortem hippocampal gene expression profiles
Mexal, S., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., & Leonard, S. S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.043 · Cited by 66
Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders
Torres, V. I., Vallejo, D., & Inestrosa, N. C. (2017) · Neural Plasticity · doi:10.1155/2017/8081758 · Cited by 71
A Comparative Proteomics Analysis of Rat Mitochondria from the Cerebral Cortex and Hippocampus in Response to Antipsychotic Medications
Ji, B., La, Y., Gao, L., Zhu, H., Tian, N., Zhang, M., Yang, Y., Zhao, X., Tang, R., Ma, G., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800876z · Cited by 73
Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication
Kumarasinghe, N., Beveridge, N. J., Gardiner, E. J., Scott, R. J., Yasawardene, S. G., Perera, A., Mendis, J., Suriyakumara, K., Schall, U., & Tooney, P. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000035 · Cited by 70
Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs
Mandel, S. A., Weinreb, O., & Youdim, M. B. H. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00067-1 · Cited by 69
Fibroblast and Lymphoblast Gene Expression Profiles in Schizophrenia: Are Non-Neural Cells Informative?
Matigian, N., McCurdy, R. D., Feron, F. P., Perry, C., Smith, H., Filippich, C., McLean, D. E., McGrath, J. J., Mackay‐Sim, A., Mowry, B. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002412 · Cited by 70
Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice
Beraki, S., Aronsson, F., Karlsson, H., Ögren, S. O., & Kristensson, K. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001545 · Cited by 67
Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients
van Beveren, N. J. M., Buitendijk, G. H. S., Swagemakers, S. M. A., Krab, L. C., Röder, C. H., de Haan, L., van der Spek, P. J., & Elgersma, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032618 · Cited by 69
MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients
Mor, E., Kano, S., Colantuoni, C., Sawa, A., Navon, R., & Shomron, N. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.011 · Cited by 67
NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection technique
Xi, D., Keeler, B. E., Zhang, W., Houlé, J. D., & Gao, W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 69
RNA Amplification in Brain Tissues
Ginsberg, S. D., & Che, S. (2002) · Neurochemical Research · doi:10.1023/a:1020944502581 · Cited by 66
Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5
Burrows, E. L., McOmish, C. E., Buret, L., van den Buuse, M., & Hannan, A. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.44 · Cited by 65
Expression of transcripts encoding AMPA receptor subunits and associated postsynaptic proteins in the macaque brain
Beneyto, M., & Meador‐Woodruff, J. H. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10981 · Cited by 67
Association study of polymorphisms in synaptic vesicle-associated genes, SYN2 and CPLX2, with schizophrenia
Lee, H. J., Song, J. Y., Kim, J.-W., Jin, S., Hong, M. S., Park, J. K., Chung, J.-H., Shibata, H., & Fukumaki, Y. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-15 · Cited by 65
The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring
Liu, S., Zhang, F., Shugart, Y. Y., Yang, L., Li, X., Liu, Z., Sun, N., Yang, C., Guo, X., Shi, J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.268 · Cited by 65
Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia.
Ruby, E., Polito, S., McMahon, K. L., Gorovitz, M., Corcoran, C. M., & Malaspina, D. (2014) · PubMed · Cited by 65

Authors: Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P.
Affiliations: University of Pittsburgh (US)
Corresponding author: Mirnics, Károly
ORCID: Mirnics, Károly
Middleton, Frank A.
Lewis, David A.
Levitt, Pat
Venue: Neuron
Publisher: Elsevier BV
Published: 2000-10
Volume: 28
Issue: 1
Pages: 53-67
ISSN: 0896-6273 (ISSN-L)
DOI: 10.1016/s0896-6273(00)00085-4
OpenAlex: W2032208151
Cited by: 882
References: 105
Citations by year: 2026: 5 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 13 · 2018: 16 · 2017: 14 · 2016: 19 · 2015: 32 · 2014: 19 · 2013: 29 · 2012: 37
FWCI: 48.20
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4672 d)
Locations: Neuron (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (T32 MH18273, MH 45156, T32MH018273, P50MH045156)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: schizophrenia, prefrontal cortex, gene expression profiling, presynaptic function, N-ethylmaleimide-sensitive factor, synapsin II, transcriptome
MeSH terms: Animals, Carrier Proteins, Female, Humans, Macaca fascicularis, Male, Middle Aged, Synaptic Transmission, RNA, Messenger, Schizophrenia, Synapses, Antipsychotic Agents, Genetic Variation, Gene Expression, Confounding Factors, Epidemiologic, Synapsins, Prefrontal Cortex, In Situ Hybridization, Presynaptic Terminals, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Vesicular Transport Proteins, N-Ethylmaleimide-Sensitive Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks